Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Hydrology Drilling to Support Scoping Study Commenced

January 17, 2025

Crypto Market Recap: SEC Dismisses Coinbase Case, Crypto...

February 24, 2025

Nolan Watson: Gold Cycle Reset Upward, Price High...

March 21, 2025

Top 10 Gold Reserves by Country

May 16, 2025

High Grade surface silver results up to 920g/t...

May 15, 2025

Biggest US Defense Contractors and ETFs in 2025

July 16, 2025

WOA Secures New Sales in Europe, Latin America...

March 10, 2025

Galan Lithium

January 7, 2025

Alvopetro Announces Year End 2024 Financial Results, Q1...

March 19, 2025

Mega M&A: Rio Tinto-Glencore Merger Talk Sparks Speculation

January 28, 2025